Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Abcellera And Abbvie Partner To Advance New Antibody Therapies

Dec 15 (Reuters) - Abcellera Biologics Inc  ABCL.O :
    * ABCELLERA AND ABBVIE PARTNER TO ADVANCE NEW ANTIBODY
THERAPIES
    * ABCELLERA BIOLOGICS INC - UNDER TERMS OF AGREEMENT, ABBVIE
HAS
RIGHT TO DEVELOP AND COMMERCIALIZE THERAPEUTIC ANTIBODIES
RESULTING FROM COLLABORATION
    * ABCELLERA-CO WILL RECEIVE RESEARCH PAYMENTS, ELIGIBLE TO
RECEIVE
DOWNSTREAM CLINICAL & COMMERCIAL MILESTONE PAYMENTS & ROYALTIES
ON NET SALES OF PRODUCTS

Source text for Eikon:  ID:nBw17m0zHa 
Further company coverage:  ABCL.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on AbCellera Biologics

See all news